Sudafed Sinus Congestion Plus Cold Severe Day Tablet, Film Coated
NDC Package 50580-659-10
Package Information
Sudafed Sinus Congestion Plus Cold Severe Day (acetaminophen, pseudoephedrine) tablets is ■ do not take more than directed (see overdose warning)adults and children 12 years and over ■ take 2 caplets every 6 hours while symptoms last ■ do not take more than 6 caplets in 24 hours, unless directed by a doctor ■ do not use for more than 10 days unless directed by a doctor children under 12 yearsask a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by Kenvue Brands Llc, this product is identified by NDC 50580-659 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1090743 - acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet
- RxCUI: 1090743 - acetaminophen 500 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet
- RxCUI: 1090743 - APAP 500 MG / Pseudoephedrine Hydrochloride 30 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50580 - Kenvue Brands Llc
- 50580-659 - Sudafed Sinus Congestion Plus Cold Severe Day
- 50580-659-10 - 1 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK
- 50580-659 - Sudafed Sinus Congestion Plus Cold Severe Day
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50580-659-10 identifies a specific commercial package of 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack of Sudafed Sinus Congestion Plus Cold Severe Day, a human over the counter drug labeled by Kenvue Brands Llc. This tablet, film coated is formulated for oral use and contains acetaminophen; pseudoephedrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kenvue Brands Llc on June 10, 2026. The current certification is valid through December 31, 2027.
How is this Kenvue Brands Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50580065910. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.